Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.
BACKGROUND: Breast cancers lacking the estrogen receptor (ER) can be distinguished from other breast cancers on the basis of poor prognosis, high grade, distinctive histopathology and unique molecular signatures. These features further distinguish estrogen receptor negative (ER-) tumor subtypes, but...
Main Authors: | M Chehani Alles, Margaret Gardiner-Garden, David J Nott, Yixin Wang, John A Foekens, Robert L Sutherland, Elizabeth A Musgrove, Christopher J Ormandy |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2650420?pdf=render |
Similar Items
-
Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer.
by: Elizabeth A Musgrove, et al.
Published: (2008-01-01) -
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
by: Lin, Charles Y., et al.
Published: (2014) -
Expression of n-MYC, NAMPT and SIRT1 in Basal Cell Carcinomas and their Cells of Origin
by: Lydia Brandl, et al.
Published: (2018-09-01) -
Protein Localization at Mitochondria-ER Contact Sites in Basal and Stress Conditions
by: Nicolò Ilacqua, et al.
Published: (2017-12-01) -
SIRT7 Represses Myc Activity to Suppress ER Stress and Prevent Fatty Liver Disease
by: Jiyung Shin, et al.
Published: (2013-11-01)